Cross-linked hyaluronic acid that integrates with the skin's matrix. Each formula contains lidocaine hydrochloride for patient comfort.
The everyday workhorse. Balanced rheology, predictable spread, clean cannula flow. The starting point for 70% of practitioners.
Conventional HA fillers cross-link in a single pass. BiViDerma cross-links in three sequential layers — each one capturing the previous one inside a denser lattice. The result: hydration that stays where it's placed, longer.
Hover or tap a region of the face to see which BiViDerma is indicated, the typical injection plane, and the volume range. This is decision support, not a clinical protocol — consult full IFU before injection.
These documents are general educational guidelines — every recommendation should be reviewed and validated with the treating physician before being applied to a patient.
Browse full PDF libraryVerified, trained, and resupplied directly by Koretreat. Filter by city and specialty.
We're expanding across LatAm. We supply ARCSA-cleared, lot-traceable inventory with margin-supportive pricing, marketing assets, and bilingual clinical training.
Koretreat Market SAS is a direct importer of certified Korean medical aesthetics. We operate from Quito, Ecuador, with ambient-controlled warehousing (5–23 °C) and bilingual clinical support.
Every product we carry meets Ecuadorian health authority standards (ARCSA) and is supplied with lot traceability, source documentation, and a 24-hour clinical hotline.
Yes — ARCSA-2023-3.3-0000041. Full documentation is available on request, and re-registrations are tracked publicly through ARCSA's portal.
BiViDerma is ambient-stable: store between 5 and 23 °C, away from direct sunlight, and do not freeze. No refrigeration is required at any point — from our Quito warehouse to your treatment room.
Most clinicians starting with BiViDerma open with III for the mid-face — it has the widest indication map and the most forgiving rheology. I and V are added once technique is established.
Yes. Every BiViDerma syringe contains 0.3% lidocaine HCl for patient comfort. Verify patient allergy history before injection.
We're actively expanding in Peru, Colombia, and Chile through our Become-a-partner program. Apply via the form on this page and a country lead will respond within 48 hours.
Use our 24/7 clinical hotline at +593 988 089 010 or email farmacovigilancia@koretreat.com. ARCSA notification is handled by us on your behalf.
Fill out the form or reach us 09:00 – 20:00 GMT-5, Mon–Fri. For 24/7 clinical support, use the hotline.
